1 |
Zhou X, Chan SW, Tseng HL, et al (2012). Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water-extracts produced by different heat water-extractions. Phytomedicine, 19, 1263-9
DOI
ScienceOn
|
2 |
Zhang L, Wu T, Chen JM, et al (2012). Danshensu inhibits acetaldehyde-induced proliferation and activation of hepatic stellate cell-T6. Zhong Xi Yi Jie He Xue Bao, 10, 1155-61
|
3 |
Zhang LJ, Chen L, Lu Y, et al (2010). Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion. Eur J Pharmacol, 643, 195-201
DOI
ScienceOn
|
4 |
Zhou L, Zuo Z, Chow MS (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol, 45, 1345-59
DOI
ScienceOn
|
5 |
Tsai TY, Chang KW, Chen CY (2011). iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. J Comput Aided Mol Des, 25, 525-31
DOI
|
6 |
Tang Y, Wang M, Chen C, et al (2011). Cardiovascular protection with danshensu in spontaneously hypertensive rats. Biol Pharm Bull, 34, 1596-601
DOI
ScienceOn
|
7 |
Tao L, Wang S, Zhao Y, et al (2012). Effect of danshensu on redox state and relevant nuclear transcription factors in non-small cell lung cancer A549 cells. Zhongguo Zhong Yao Za Zhi, 37, 1265-8 (in Chinese).
|
8 |
Trott O, Olson AJ (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem, 31, 455-61
|
9 |
Utomo DH, Widodo N, Rifa'i M (2012). Identifications small molecules inhibitor of p53-mortalin complex for cancer drug using virtual screening. Bioinformation, 8, 426-9
DOI
ScienceOn
|
10 |
van der Burgt I, Kupsky W, Stassou S, et al (2007). Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation. J Med Genet, 44, 459-62
DOI
|
11 |
Wang JC, Chu PY, Chen CM, et al (2012). idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach. Nucleic Acids Res, 40, W393-9
DOI
|
12 |
Lee CY, Sher HF, Chen HW, et al (2008). Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol Cancer Ther, 7, 3527-38
DOI
ScienceOn
|
13 |
Yin Y, Guan Y, Duan J, et al (2013). Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol, 699, 219-26
DOI
ScienceOn
|
14 |
Zhang J, Matthews CR (1998). Ligand binding is the principal determinant of stability for the p21(H-ras) protein. Biochemistry, 37, 14881-90
DOI
ScienceOn
|
15 |
Li XJ, Kong DX and Zhang HY (2010). Chemoinformatics approaches for traditional Chinese medicine research and case application in anticancer drug discovery. Curr Drug Discov Technol, 7, 22-31
DOI
|
16 |
Li H, Xie YH, Yang Q, et al (2012). Cardioprotective effect of paeonol and danshensu combination on isoproterenolinduced myocardial injury in rats. PLoS One, 7, e48872
DOI
|
17 |
Li HY, Li Y, Yan CH, et al (2002). Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. J Asian Nat Prod Res, 4, 271-80
DOI
ScienceOn
|
18 |
Li YJ, Han D, Xu XS, et al (2012). Protective effects of 3,4-dihydroxyphenyl lactic acid on lipopolysaccharideinduced cerebral microcirculatory disturbance in mice. Clin Hemorheol Microcirc, 50, 267-78
|
19 |
Liu X, Ouyang S, Yu B, et al (2010). PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res, 38, W609-14
DOI
|
20 |
Membrino A, Cogoi S, Pedersen EB, et al (2011). G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy. PLoS One, 6, e24421
DOI
|
21 |
Feng LX, Jing CJ, Tang KL, et al (2011). Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis. Proteomics, 11, 1473-85
DOI
|
22 |
Omerovic J, Laude AJ, Prior IA (2007). Ras proteins: paradigms for compartmentalised and isoform-specific signalling. Cell Mol Life Sci, 64, 2575-89
DOI
|
23 |
Pai EF, Krengel U, Petsko GA, et al (1990). Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. EMBO J, 9, 2351-9
|
24 |
Silvius JR (2002). Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol, 190, 83-92
DOI
|
25 |
Chen YZ, Ung CY (2001). Prediction of potential toxicity and side effect protein targets of a small molecule by a ligandprotein inverse docking approach. J Mol Graph Model, 20, 199-218
DOI
|
26 |
Chen YZ, Zhi DG (2001). Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins, 43, 217-26
DOI
|
27 |
Chen Z, Wang X, Zhu W, et al (2011). Acenaphtho[1,2-b]pyrrolebased selective fibroblast growth factor receptors 1 (FGFR1) inhibitors: design, synthesis, and biological activity. J Med Chem, 54, 3732-45
DOI
|
28 |
Grinter SZ, Liang Y, Huang SY, et al (2011). An inverse docking approach for identifying new potential anti-cancer targets. J Mol Graph Model, 29, 795-9
DOI
|
29 |
Gripp KW, Lin AE (2012). Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med, 14, 285-92
DOI
|
30 |
Hui-fang L, Qing S, Jian Z, et al (2010). Evaluation of various inverse docking schemes in multiple targets identification. J Mol Graph Model, 29, 326-30
DOI
|
31 |
Husna B, On T, Zhu YZ (2007). Effects of purified Salvia miltiorrhiza extract on cardiac vascular smooth muscle hypoxic cells. J Pharmacol Sci, 104, 202-11
DOI
|
32 |
Kai K, Iwamoto T, Kobayashi T, et al (2013). Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triplenegative breast cancer containing tumorigenic CD49f(-) quiescent cells. Oncogene, ????
|
33 |
Kamper A, Apostolakis J, Rarey M, et al (2006). Fully automated flexible docking of ligands into flexible synthetic receptors using forward and inverse docking strategies. J Chem Inf Model, 46, 903-11
DOI
|
34 |
Bhattacharjee B, Chatterjee J (2013). Identification of proapoptopic, anti-inflammatory, anti-proliferative, antiinvasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pac J Cancer Prev, 14, 3735-42
DOI
ScienceOn
|
35 |
Abreu RM, Froufe HJ, Queiroz MJ, et al (2012). Selective flexibility of side-chain residues improves VEGFR-2 docking score using AutoDock Vina. Chem Biol Drug Des, 79, 530-4
DOI
|
36 |
Bharate SB, Singh B, Vishwakarma RA (2012). Modulation of k-Ras signaling by natural products. Curr Med Chem, 19, 2273-91
|
37 |
Bhattacharjee B, Vijayasarathy S, Karunakar P, et al (2012). Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pac J Cancer Prev, 13, 5605-11
과학기술학회마을
DOI
ScienceOn
|
38 |
Chen CY (2011). TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One, 6, e15939
DOI
|
39 |
Buhrman G, de Serrano V, Mattos C (2003). Organic solvents order the dynamic switch II in Ras crystals. Structure, 11, 747-51
DOI
|
40 |
Chan K, Chui SH, Wong DY, et al (2004). Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sci, 75, 3157-71
DOI
ScienceOn
|
41 |
Chen K, Kurgan L (2009). Investigation of atomic level patterns in protein--small ligand interactions. PLoS One, 4, e4473
DOI
|